GeneralConnection.com ➔ Dictionary
Dictionary Search

sle

Synonyms

Noun

1. systemic lupus erythematosus

2. SLE, disseminated lupus erythematosus, lupus

Usage
CASE: CAR T-Cell Therapy for Lupus Patient With Kidney Involvement - Cleveland Clinic
Study Finds Increased Risk of Kidney Disease in People with Systemic Lupus Erythematosus Without Lupus Nephritis - Lupus Foundation of America
Anifrolumab Shows Real-World Promise in Systemic Lupus Erythematosus - European Medical Journal
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis - BioSpace
SLE program offers glimpse of West Point’s immense possibilities for prospective high school students - army.mil
Positioning rituximab in the therapeutic strategies for SLE - Frontiers
SLE program offers glimpse of West Point’s immense possibilities for prospective high school students - DVIDS
Randomized Trial Supports Sirolimus as Add-On Systemic Lupus Erythematosus Therapy - Medscape
Factors Associated With Fatigue in Systemic Lupus Erythematosus Identified - Docwire News
First-of-Its-Kind Lupus Treatment Significantly Reduces Symptoms in Mice - ScienceAlert
Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial - The Lancet
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus - Biogen
Nipocalimab Shows 58% Response Rate in Autoantibody-Positive SLE Patients - The Clinical Trial Vanguard
Prasugrel inhibits TLR7-driven autoimmunity in systemic lupus erythematosus by acetylating cGAS - Nature
Immune-Mediated Demyelinating Polyradiculoneuropathies Linked to Systemic Lupus Erythematosus (SLE): A Systematic Review of Clinical Features, Diagnostic and Treatment Modalities - Cureus
Johnson & Johnson reports phase 2 data showing nipocalimab reduced SLE disease activity - PharmaTimes
SLE: four trials to watch in 2026 - Clinical Trials Arena
Study finds Anifrolumab may help restore overall immune health in people with systemic lupus erythematosus - Lupus Foundation of America
FDA Accepts Supplemental Biologics Application for Gazyva® in Systemic Lupus Erythematosus - Lupus Foundation of America
Nipocalimab Reduces Disease Activity in Moderate-to-Severe SLE in Phase 2 Trial - HCPLive
Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial - Nature
Update: Gazyva® significantly reduces disease activity in adults with systemic lupus erythematosus - Lupus Foundation of America
FDA approves AstraZeneca’s Saphnelo for SLE - Pharmaceutical Technology
New Study Finds Potential Biomarker Linking Fat Imbalance to Systemic Lupus Erythematosus - Lupus Foundation of America
Update: Dapirolizumab pegol plus standard of care improves disease activity in systemic lupus erythematosus - Lupus Foundation of America
Aurinia Unchanged on Unveiling Lupus Treatment - Baystreet.ca
Fast-paced Momentum Stock Super League Enterprise (SLE) Is Still Trading at a Bargain - Yahoo Finance
Using objective measures of physical activity, sleep, and breathing for disease profiling of patients with systemic lupus erythematosus and Sjögren's disease - Frontiers
Saphnelo SC Approval Expands Delivery Options for SLE Patients - Clinical Advisor
A Case of Systemic Lupus Erythematosus Initially Presenting With Generalized Lymphadenopathy: A Diagnostic Challenge - Cureus
FDA Accepts BLA for Gazyva/Gazyvaro for Systemic Lupus Erythematosus - BioPharm International
Complement and autoantibody levels under anifrolumab therapy in SLE: implications for clinical practice - Frontiers
How The Investment Story For Super League Enterprise (SLE) Is Shifting After Analyst Reset - Yahoo Finance
Efficacy of mebendazole in the spontaneous NZBxNZWF1 animal model of systemic lupus erythematosus - Nature
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis - The Norfolk Daily News
UPDATE: FDA Grants Fast Track Designation to Johnson & Johnson’s Investigational Therapy, Nipocalimab, for Adults with Systemic Lupus Erythematosus - Lupus Foundation of America
Alterations in peripheral blood B cell subsets and their clinical significance in systemic lupus erythematosus - Nature
FDA Approves First-in-Class Weekly Anifrolumab Autoinjector for Systemic Lupus Erythematosus - AJMC
Encouraging New Developments Reported on Investigational Therapy, CLN-978, for Treatment of Systemic Lupus Erythematosus - Lupus Foundation of America
Obinutuzumab Under Review for Systemic Lupus Erythematosus - Medical Professionals Reference
FDA Approves SAPHNELO Self-Administration for Treatment of Systemic Lupus Erythematosus - Lupus Foundation of America
Study reveals link between cytomegalovirus infection and systemic lupus erythematosus - Lupus Foundation of America
Azathioprine Exposure Associated with Liver Condition in Systemic Lupus Erythematosus Pregnancies - Lupus Foundation of America
SLE and LN market expected to reach $5.9bn across 7MM by 2034 - Pharmaceutical Technology
The microbiota-systemic lupus erythematosus axis: mechanisms, diagnostics, and therapeutic frontiers - Frontiers
TLR7/8 Inhibitor Reduces Cutaneous Disease Activity in SLE - European Medical Journal
Early Steroid Pulses Tied to Lower Damage/Death Risk in SLE - Medscape
Belimumab Monotherapy Matches Combination Therapy in Systemic Lupus Erythematosus - Medscape
Applications of artificial intelligence in systemic lupus erythematosus: integrating multi-omics data for precision medicine - Frontiers
Severe Acquired Long QT Syndrome in Childhood-Onset Systemic Lupus Erythematosus: - JACC Journals
Phase IIb Study Results of InnoCare’s Orelabrutinib in Patients with SLE Presented at 2026 EULAR - Yahoo Finance
Case Report: Telitacicept in the treatment of systemic lupus erythematosus complicated by acquired hemophilia A - Frontiers
FDA Approves Anifrolumab-fnia Autoinjector for SLE Self-Administration, Offering Subcutaneous Option - Pharmacy Times – Pharmacy Practice News and Expert Insights
Clinical and Immunological Profiles With Treatment Patterns in Systemic Lupus Erythematosus Patients in the Eastern Part of India: A Retrospective, Hospital-Based, Cross-Sectional Study - Cureus
A Case of a 31-Year-Old Female Patient With Systemic Lupus Erythematosus Presenting With Lupus-Associated Pleural Effusions and Newly Diagnosed Lupus Nephritis - Cureus
Immunopathogenesis of accelerated atherosclerosis in systemic lupus erythematosus: from innate and adaptive dysregulation to clinical implications - Frontiers
Two Cases of Systemic Lupus Erythematosus With Castleman Disease - Cureus
Bullous Systemic Lupus Erythematosus as a Marker of Treatment-Refractory Systemic Disease: A Case Report - Cureus
Advances in understanding the Th17/Treg balance in systemic lupus erythematosus: implications for treatment and management - Frontiers
SLE Market Evolution Accelerates as AstraZeneca’s Saphnelo SC Emerges as a Likely Key Challenger to GSK’s Benlysta - Yahoo Finance
Bullous Systemic Lupus Erythematosus in a Male Child With Lupus Nephritis: A Rare Pediatric Presentation - Cureus
Successful Treatment of Pure Red Cell Aplasia in Systemic Lupus Erythematosus With a Combination of Rituximab and Mycophenolate Mofetil - Cureus
SLE Q1 2026 Earnings: EPS Beats Estimates Despite Revenue Challenges - Net Income Trends - dars.gov.et
Systemic Lupus Erythematosus-Associated Myelitis Mimicking Spinal Glioblastoma: A Case Report - Cureus
American College of Rheumatology Releases 2025 Treatment Guideline for SLE - Dermatology Advisor
Kikuchi-Fujimoto Disease Associated With Systemic Lupus Erythematosus Presenting With Prominent Cutaneous Manifestations: A Case Report - Cureus
Experts Call for Multimodal Pain Management in Systemic Lupus Erythematosus - Physician's Weekly
SLE Technologies Named Authorized Car-O-Liner® Distributor for Indiana, Northern Kentucky, and Western Ohio - Business Wire
Systemic Lupus Erythematosus: Emerging Insights into Diagnosis, Treatment, and Prognosis - Science Partner Journals
Systemic Lupus Erythematosus Clinical Trial Pipeline - GlobeNewswire
CAR-T Cell Therapy Induces Durable Remission in SLE - European Medical Journal
Cost-utility analysis of telitacicept versus belimumab in the treatment of systemic lupus erythematosus in China - Frontiers
Neuropsychiatric Systemic Lupus Erythematosus Diagnosed Following Treatment Initiated for Acute Encephalitis - Cureus
New study identifies 15 herbal supplements to potential skin flare activity in people with autoimmune skin diseases - Lupus Foundation of America
Systemic lupus erythematosus: BCMA–CD19 dual CAR-T may deliver a deeper humoral reset than CD19 alone - Vera Health
Peterborough Hospital to trial treatment for autoimmune condition - BBC
Acute Psychosis as the Sole Initial Manifestation of Systemic Lupus Erythematosus: A Diagnostic Challenge - Cureus
BLyS-Specific Inhibition for Active Systemic Lupus Erythematosus and Lupus Nephritis to Improve Patient Outcomes - Rheumatology Advisor
Feel like you’re walking on another planet at Ah-Shi-Sle-Pah - Albuquerque Journal
Sixth Street Raises €3.75 Billion for Third European Direct Lending Fund - Sixth Street
Rapid response to anifrolumab in refractory systemic lupus erythematosus - Elsevier
Anifrolumab yields remission at 6 months in 26% of real-world lupus cohort - Healio
Crohn's disease in patients with systemic lupus erythematosus - Elsevier
A practical perspective on gastrointestinal manifestations of systemic lupus erythematosus - Elsevier
Challenges in the Diagnosis of Systemic Lupus Erythematosus in an Adolescent With Sexually Transmitted Infections: A Case Report and Review of the Literature - Cureus
Crohn's disease in patients with systemic lupus erythematosus - Elsevier
Brainstem Encephalitis in Neuropsychiatric Systemic Lupus Erythematosus Mimicking Malignant Lymphoma: A Case Report and Literature Review - Cureus
SLE Q1 2026 Earnings: EPS Surprises to the Upside Despite Revenue Uncertainty; Stock Slips - Strong Earnings Momentum - dars.gov.et
Case Report: Biologic-free clinical remission following anifrolumab discontinuation in systemic lupus erythematosus—two-case reports - Frontiers
Saphnelo® subcutaneous approved in Canada for the treatment of systemic lupus erythematosus - Bioscience Association Manitoba
Mechanistic link uncovered between EBV infection and SLE - Nature
Single-cell profiling unveils nephritis-related circulating immunological signatures in systemic lupus erythematosus patients - Nature
Phase III Study Shows Positive Results for Gazyva® in Systemic Lupus Erythematosus - Lupus Foundation of America
Loss-of-function mutations in PLD4 lead to systemic lupus erythematosus - Nature
EBV and SLE: causal or concurrence? - The Lancet
Effects of telitacicept and belimumab on systemic lupus erythematosus: a systematic review and meta-analysis - Nature
Acute Pericarditis: An Isolated Initial Manifestation of Systemic Lupus Erythematosus (SLE) - Cureus
Nipocalimab Delivers Positive Phase IIb Results in JASMINE SLE Trial - Applied Clinical Trials Online
Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trial - Nature
Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus at ACR Convergence 2025 - Biogen
Foreign Language Equivalents
Foreign Language Equivalents of 'sle'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
s;e,   ale,   dle,   ssle,   slw,   slr,   sl,   slee,   ske,   le,   se,   lse,   sel,   slle
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z